RAP 0.00% 20.5¢ resapp health limited

Ann: Publication on challenges of diagnosing respiratory disease, page-44

  1. 6,758 Posts.
    lightbulb Created with Sketch. 858
    The Indian team doing the test in India are also conduct clinical trials do they not? Big plus here! This may be faster and bigger than we first thought as they may have the clout to whizz it through the Indian system. That would pave the way for CE and screening tool status in USA...first and foremost don't sell share in RAP...go do your soul some good and buy a few more.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.